Literature DB >> 32221699

Solid cancer risk dependence on the Pasquill-Gifford atmospheric stability classes in a radiological event.

Valquiria M Bulhosa1, Renata P N Funcke1, Tercio Brum2, Juliana S Sanchez1, Zelmo R Lima1, Hélio C Vital3, Matjaž Prah4, Edson R Andrade5,6.   

Abstract

In a radiological event, the lack of preliminary information about the site of explosion and the difficulty in predicting the accurate path and distribution of radioactive plumes makes it difficult to predict expected health effects of exposed individuals. So far, in such a health evaluation, radiation-induced stochastic health effects such as cancer are not included. The Pasquill-Gifford atmospheric classes generally allow connecting atmospheric stability with dispersion of radioactive contaminants to the environment. In this work, an environmental release of radioactive Cs-137 was simulated and the resulting relative risk for solid cancer incidence among the affected population calculated. The HotSpot health physics code was used to simulate the radioactive atmospheric dispersion and calculate the Total Effective Dose Equivalent (TEDE), which was then used to estimate the relative risk of cancer incidence. The main results from this work suggest that the relative cancer risk and atmospheric stability classes are linked by differences in the TEDE. Such a finding may support triage, because it adds additional information on the potentially affected population at the early stages of an emergency response.

Entities:  

Keywords:  Environmental radiation; Gaussian simulation; Relative risk; Solid cancer

Mesh:

Substances:

Year:  2020        PMID: 32221699     DOI: 10.1007/s00411-020-00840-3

Source DB:  PubMed          Journal:  Radiat Environ Biophys        ISSN: 0301-634X            Impact factor:   1.925


  11 in total

1.  The 2007 Recommendations of the International Commission on Radiological Protection. ICRP publication 103.

Authors: 
Journal:  Ann ICRP       Date:  2007

2.  Modeling of the EMRAS urban working group hypothetical scenario using the RESRAD-RDD methodology.

Authors:  S Kamboj; J-J Cheng; C Yu; S Domotor; A Wallo
Journal:  J Environ Radioact       Date:  2009-04-28       Impact factor: 2.674

3.  Development of realistic RDD scenarios and their radiological consequence analyses.

Authors:  Hyeongki Shin; Juyoul Kim
Journal:  Appl Radiat Isot       Date:  2009-02-20       Impact factor: 1.513

4.  Radiological risk assessment caused by RDD terrorism in an urban area.

Authors:  Hyojoon Jeong; Misun Park; Haesun Jeong; Wontae Hwang; Eunhan Kim; Moonhee Han
Journal:  Appl Radiat Isot       Date:  2013-04-25       Impact factor: 1.513

5.  Preliminary evaluation of (135)Cs/(137)Cs as a forensic tool for identifying source of radioactive contamination.

Authors:  V F Taylor; R D Evans; R J Cornett
Journal:  J Environ Radioact       Date:  2007-09-14       Impact factor: 2.674

6.  Medical effects and risks of exposure to ionising radiation.

Authors:  Fred A Mettler
Journal:  J Radiol Prot       Date:  2012-03-06       Impact factor: 1.394

7.  Support to triage and public risk perception considering long-term response to a Cs-137 radiological dispersive device scenario.

Authors:  Cristiane Ps Andrade; Cláudio J Souza; Eduardo Sn Camerini; Isabela S Alves; Hélio C Vital; Matthew Jf Healy; Edson Ramos De Andrade
Journal:  Toxicol Ind Health       Date:  2018-04-17       Impact factor: 2.273

8.  Accidental Cs-137 contamination.

Authors:  H Nishiyama; E L Saenger; L W Grossman; S J Lukes
Journal:  Radiology       Date:  1985-02       Impact factor: 11.105

9.  Radiological Risk Assessment by Convergence Methodology Model in RDD Scenarios.

Authors:  Fagner C Rother; Wilson F Rebello; Matthew J F Healy; Mauricio M Silva; Paulo A M Cabral; Hélio C Vital; Edson R Andrade
Journal:  Risk Anal       Date:  2016-02-19       Impact factor: 4.000

10.  Solid cancer incidence in atomic bomb survivors: 1958-1998.

Authors:  D L Preston; E Ron; S Tokuoka; S Funamoto; N Nishi; M Soda; K Mabuchi; K Kodama
Journal:  Radiat Res       Date:  2007-07       Impact factor: 2.841

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.